P. Kaur

N-sulfonylated indole hydrazone hybrid targeting Staphylococcus aureus with compelling antibiofilm and membrane-disrupting properties.

Findings highlight the compound 5d as a promising scaffold against S. aureus infections and successfully establish the sulfonylated-indole hydrazones as capable pharmacophores for next-generational antibacterial drug discovery efforts to mitigate the global AMR burden.